ArticleJournal of minimal access surgery2026
Long-term outcomes of endoscopic pilonidal sinus treatment: A single tertiary centre experience.
Article in Journal of minimal access surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPilonidal sinus disease commonly affects young adults and presents a clinical challenge due to high recurrence rates. This study aims to evaluate long-term outcomes following Endoscopic Pilonidal Sinus Treatment (EPSIT) performed at a UK district general hospital. PATIENTS AND
methodsWe conducted a retrospective observational study of all adult patients who underwent EPSIT by a single colorectal surgeon between January 2015 and May 2022. Patients with acute abscesses or previous extensive surgery were excluded. Outcomes included healing rate, recurrence and need for further intervention, assessed through structured clinical follow-up and telephone review until March 2024.
resultsEighty-seven patients (62 men, median age: 31 years) underwent EPSIT. Twenty-one procedures were performed under local anaesthesia. The median follow-up was 62 months (range: 24-108). Short-term healing was achieved in 70 patients (84%), with 13 requiring additional intervention (repeat EPSIT or flap). At long-term follow-up, 52 patients were fully evaluated. Of these, 41 (79%) achieved durable healing after a single EPSIT. Six had recurrence and were managed conservatively, and four patients await surgery. Twenty-five patients were lost to follow-up. If assuming the best-case scenario (all healed), the overall long-term success rate would be 76%; worst-case scenario (none healed) gives 47%. Healing was confirmed clinically or through patient self-report of complete resolution of discharge and symptoms.
conclusionEPSIT is a minimally invasive approach with promising long-term results when carefully selected patients are treated by trained surgeons. However, high attrition rates limit interpretation. Larger comparative studies with standardised outcome definitions and inclusion of patient-reported outcomes (pain and cosmesis) are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.